Both in Pharmaceuticals
CorMedix vs Indaptus Therapeutics
Over the past year CRMD returned −50.4% and INDP returned +16.2%; their daily moves had a correlation of 0.03.
CRMD −50.4% INDP +16.2%Growth of $1, one year, split-adjusted
| Metric | CRMD | INDP |
|---|---|---|
| Price | $5.66 | $3.30 |
| Market cap | $441.2M | $439.7M |
| Today | +1.80% | +1.85% |
| 1 month | −22.3% | +27.4% |
| 6 months | −29.7% | +61.0% |
| Year to date | −51.3% | +13.4% |
| 1 year | −51.0% | +5.8% |
| Revenue growth (YoY) | +156.5% | — |
| Gross margin | 75.7% | — |
| Net margin | 25.5% | — |
| P/E (TTM) | 2.4× | — |
| Price / sales | 1.0× | — |
| Net cash | $256.7M | $11.6M |
| Dividend yield | — | — |
| Volatility (60d) | 77.3% | 193.4% |
| Short % of float | 20.8% | 7.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).